Frequently Asked Questions

The Radiation Oncology Program will be administered by AIM Specialty Health on behalf of your patients’ health plans. AIM Specialty Health, a separate company, collaborates with payors to help improve health care quality and manage costs for some of today’s complex tests and treatments, promoting patient care that’s appropriate, safe, and affordable.

We review certain treatment plans against clinical appropriateness criteria to help ensure that care aligns with established medical best practices. To request review of treatment plans, providers should contact AIM for the radiation therapy modalities and services as noted below:

Pre-certification
Providers contact AIM to obtain pre-certification for the following non-emergency, outpatient radiation therapy modalities:

  • Brachytherapy
  • Intensity Modulated Radiation Therapy (IMRT)
  • Proton Beam Radiation Therapy (PBRT)
  • Stereotactic Radiosurgery (SRS) / Stereotactic Body Radiotherapy (SBRT)
  • 3D Conformal Therapy* (EBRT) for bone metastases and breast cancer

Services that may also require review:

  • Review for hypo fractionation for bone metastases, lung cancer or breast cancer when requesting EBRT and IMRT
  • Special procedures and consultations associated with a treatment plan (CPT codes 77370 and 77470)
  • Image Guidance Radiation Therapy (IGRT)
  • Radiopharmaceuticals, including Ibritumomam tiuxetan, Lutetium Lu 177 dotatate, and Radium 223 dichloride

Radiation therapy performed as part of an inpatient admission will be reviewed through the patient’s health plan, if applicable.

*Pre-notification for 3-D Conformal Radiation Therapy (EBRT) For EBRT, pre-certification is required for procedures involving bone metastases, lung cancer (NSCLC), and breast cancer.

We are collecting this information to obtain a more complete understanding of the broad range of radiation therapy services being delivered for health plan members. Review will be performed to ensure the ordering physician is aware of alternative treatments where applicable. Once review is completed a confirmation/tracking number will be issued. Claims will not be denied as a result of the pre-notification process.

Please contact AIM through the following processes:

  • Online via AIM ProviderPortalSMProviderPortal is available 24/7. It is fully interactive, processing requests in real-time. The ProviderPortal may be accessed directly at www.providerportal.com. Registration is required.
  • By phone, using the dedicated phone number available from your patient’s health plan.

A step-by-step tutorial on using the AIM ProviderPortal to submit your regimen can be accessed online, here.

Providers are strongly encouraged to verify that an order number has been obtained before initiating, scheduling and performing services.

Please refer to the Radiation Oncology Request Checklist on our Resources page.

For orders requiring prior authorization, AIM will review requests against AIM proprietary clinical guidelines as well as health plan medical policy, and/or Local Coverage Determinations (LCDs) if applicable.

If the request meets medical necessity criteria based on the information submitted by the ordering provider’s office, the provider will receive an order number. If the request does not immediately meet criteria, the case will be forwarded to a nurse for additional clinical review. Nurse reviewers will request additional information regarding the case. If the additional information necessary confirms that the case is consistent with program guidelines, the provider will then receive an order number.

If, with the additional information the case still does not meet criteria, the case will be forwarded to a physician reviewer. Upon review, the physician reviewer may issue an order number or issue an adverse determination. The ordering provider will be notified of the final outcome for the request.

For EBRT, pre-certification is required only for procedures involving bone metastases, lung cancer (NSCLC), and breast cancer. Additionally, we are requesting that providers contact AIM to review all other 3D-conformal therapy requests on a voluntary basis.

Requests that meet criteria receive a response instantly on screen in the AIM ProviderPortal or on the phone with the AIM contact center.

Upon approval, AIM will provide the ordering physician with an order number, which will be valid for 90 days from the initial treatment date. Issuance of an order number is not a guarantee of payment. When submitted, the claim will be processed in accordance with the terms of the member’s health benefit plan.

The order reflects an expected maximum duration of treatment of 90 days. If treatment continues beyond 90 days, please submit a new treatment regimen request to AIM. Most users will find the most efficient way to track the order request time period is to save the summary page that you receive from the AIM ProviderPortal, after completing your initial order in your patients’ charts, so that the information to report continuation of treatment is easily available.